News

ARS Pharmaceuticals recently announced its nasal spray for type 1 allergic reactions has received FDA approval.

A recently published case study described a 4-year-old girl with both amyloid myeloid leukemia (AML) and systemic mastocytosis (SM).

A recent study found targeting eosinophils in nonadvanced SM may help those who have not found success with other treatments.

A recent study showed SM can be associated with severe complications and atypical symptoms, highlighting the need for a uniform diagnostic approach.

According to a recent study, chest CT scans are able to identify bronchial or lung lesions in patients with systemic mastocytosis (SM).

Lupin Limited recently announced it has received approval from the FDA for its midostaurin 25 mg capsules to treat aggressive SM.

According to a recently-published article, increased knowledge and awareness of systemic mastocytosis is needed among specialists.

A recent study found a genetic association between the KIT M541L variant and mastocytosis—SM and CM, in particular.

Long COVID, which is also called long-term COVID or post-COVID syndrome, may be linked to mast cell activation syndrome (MCAS).

A recent report shows increased awareness of systemic mastocytosis (SM) is associated with fewer diagnostic delays, which leads to better patient care.